<p dir="ltr"><i>Streptomyces</i> are a fruitful source of natural products (NPs) with important biological activities; however, the recent discovery of novel NPs from this genus was greatly diminished until bioinformatics revealed a bounty of silent, or unexpressed, biosynthetic gene clusters (BGCs). One of the ways these BGCs are regulated is through repressors which bind functionalized γ-butyrolactone or γ-butenolide signaling molecules. By leveraging these pathways, novel NPs can be accessed. However, since these molecules are isolated in sub-nanomolar concentrations from their respective species and are challenging to access synthetically due to their dense substitution patterns and numerous stereocenters, their relationship with their cognate repressors is understudied. Discussed herein are the synthetic efforts towards four classes of signaling molecules: A-Factor, the <i>Streptomyces coelicolor </i>butanolides (SCBs), and the <i>Streptomyces ansochromogenes</i> and <i>rochei</i> butenolides (SABs/SRBs, respectively). Through accessing common core scaffolds, a library of enantio-pure compounds has been synthesized through chemical and biocatalytic techniques.</p>